Insulin Prevents Latent Skin Lesions by Inhibiting the Generation of Advanced Glycation End Products in Streptozotocin-Induced Diabetic Rats

被引：14

作者：

Chen, Xiangfang ^{[1
]}

Lin, Weidong ^{[2
]}

Lu, Shuliang ^{[3
]}

Shi, Yongquan ^{[1
]}

Zou, Junjie ^{[1
]}

Liu, Zhimin ^{[1
]}

Liao, Wanqing ^{[4
]}

机构：

[1] Second Mil Med Univ, Dept Endocrinol, Chang Zheng Hosp, Shanghai 200003, Peoples R China

[2] Shanghai Fire Corps Hosp Chinese Peoples Armed Po, Dept Burns, Shanghai 200443, Peoples R China

[3] Jiao Tong Univ, Shanghai Burns Inst, Burns Dept, Ruijin Hosp, Shanghai 20025, Peoples R China

[4] Second Mil Med Univ, Dept Dermatol, Chang Zheng Hosp, Shanghai 200003, Peoples R China

来源：

ENDOCRINE PATHOLOGY | 2009年 / 20卷 / 03期

关键词：

diabetes mellitus; advanced glycation end products; insulin; CROSS-LINKING; GLYCEMIC CONTROL; IN-VITRO; COMPLICATIONS; ENDPRODUCTS; COLLAGEN; FOOT; AUTOFLUORESCENCE; KERATINOCYTES; FIBROBLASTS;

D O I：

10.1007/s12022-009-9084-0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The preventive effect of insulin on latent skin lesions in streptozotocin-induced diabetic rats was investigated. Diabetes was induced in 72 male Sprague-Dawley rats, with 36 rats serving as the control group. Half of the diabetic rats were treated with insulin, and the other half were injected with vehicle. Skin tissues were collected 4, 8, and 12 weeks after the initiation of insulin therapy for measurement of glucose, collagen-related fluorescence and advanced glycation end product (AGE) expression, and histological observation. The diabetic rats exhibited changes in skin tissue, including a decrease in thickness, disappearance of the multilayer epithelium structure, degeneration of collagen fibers, and an increase in the infiltration of inflammatory cells, in addition to a significant increase in blood glucose and AGE expression. These effects were greatly ameliorated by insulin therapy. Insulin therapy in early-stage diabetes mellitus prevents potential skin lesions, possibly by inhibiting AGE formation and inflammatory reactions following glycemic control.

引用

页码：163 / 169

页数：7

共 26 条

[1] Diabetes mellitus
Ahmed, Intekhab
Goldstein, Barry
[J]. CLINICS IN DERMATOLOGY, 2006, 24 (04) : 237 - 246
[2] Advanced glycation endproducts: what is their relevance to diabetic complications?
Ahmed, N.
Thornalley, P. J.
[J]. DIABETES OBESITY & METABOLISM, 2007, 9 (03) : 233 - 245
[3] Advanced glycation endproducts - role in pathology of diabetic complications
Ahmed, N
[J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2005, 67 (01) : 3 - 21
[4] Off-loading the diabetic foot wound - A randomized clinical trial
Armstrong, DG
van Schie, CHM
Nguyen, HC
Boulton, AJM
Lavery, LA
Harkless, LB
[J]. DIABETES CARE, 2001, 24 (06) : 1019 - 1022
[5] Bannai C, 1992, Diabetes Res, V20, P87
[6] Bitar MS, 1998, AM J PATHOL, V152, P547
[7] The Diabetic Foot
Bloomgarden, Zachary T.
[J]. DIABETES CARE, 2008, 31 (02) : 372 - 376
[8] Detection and characterisation of microcirculatory abnormalities in the skin of diabetic patients with microvascular complications
Brooks, Belinda A.
McLennan, Susan V.
Twigg, Stephen M.
Yue, Dennis K.
[J]. DIABETES & VASCULAR DISEASE RESEARCH, 2008, 5 (01) : 30 - 35
[9] Autologous fibroblasts to treat deep and complicated leg ulcers in diabetic patients
Cavallini, Marco
[J]. WOUND REPAIR AND REGENERATION, 2007, 15 (01) : 35 - 38
[10] Chemokines, cytokines, and growth factors in keratinocytes and dermal endothelial cells in the margin of chronic diabetic foot ulcers
Galkowska, Hanna
Wojewodzka, Urszula
Olszewski, Waldemar L.
[J]. WOUND REPAIR AND REGENERATION, 2006, 14 (05) : 558 - 565

← 1 2 3 →